Image Credit: Scientific Frontline
Scientific Frontline: Extended "At a Glance" Summary: Silver Nanoparticles for DNA Cutting and Joining
The Core Concept: A novel genetic engineering technology utilizing silver nanoparticles to precisely cleave and assemble DNA at targeted sites, achieving two to five times higher efficiency than conventional methods.
Key Distinction/Mechanism: Traditional DNA assembly relies on restriction enzymes that cut at limited, specific sequences and produce short overhanging sequences ("sticky ends"). This new method uses chemical cleavage via polyethylene glycol (PEG)-coated silver nanoparticles targeting 3′-thiol-modified DNA. This allows for the generation of significantly longer sticky ends (up to 18 bases) and enables the physical removal of unwanted DNA fragments through centrifugation, resulting in a 98% DNA recovery rate.
Major Frameworks/Components:
- Silver Nanoparticles: The primary chemical agents used to induce targeted DNA cleavage.
- Polyethylene Glycol (PEG) Coating: A water-soluble polymer applied to the nanoparticles to ensure chemical stability, dispersion, and high efficiency at ambient temperatures (50°C).
- 3′-Thiol-Modified DNA: The specific oligonucleotide modification targeted by the nanoparticles to initiate precise strand cleavage.
- Long Sticky Ends: Extended single-stranded DNA overhangs (8 to 18 bases long) created by the cleavage process, which drastically improve fragment binding.
- T4 DNA Ligase: The standard enzyme utilized to permanently join the newly generated, highly compatible DNA fragments.
Branch of Science: Molecular Biology, Genetic Engineering, Nanotechnology, and Biochemistry.
Future Application: The synthesis of genome-scale DNA, the establishment of mRNA libraries for cancer vaccines, advanced gene therapy, the development of artificial protein drugs, and the creation of genetically modified crops.
Why It Matters: By overcoming the sequence limitations and low joining efficiencies of traditional restriction enzymes, this technology provides a highly accurate and scalable tool for manipulating long-chain DNA. This accelerates advanced genetic engineering and expands the possibilities for complex drug discovery and genomic research.
This technology achieves two to five times higher DNA assembly efficiency than conventional restriction enzyme methods.
DNA is composed of long chains that act as the blueprint for living organisms. In genetic engineering, scientists cut DNA at specific sites and join the resulting fragments to other DNA sequences, enabling applications such as advanced crop breeding, genetic disease treatment, and the generation of animal models for drug discovery.
Assembling short DNA fragments requires overhanging sequences, known as sticky ends, to facilitate efficient binding. However, generating sticky ends requires precise cutting at targeted sites, which remains challenging with current technologies.
A Japanese research group has developed a silver nanoparticle-based technology to precisely cut and join DNA at targeted sites, achieving two to five times higher DNA assembly efficiency than conventional restriction enzyme methods. These findings were published in the journal Nucleic Acids Research.
Traditional long-chain DNA assembly uses restriction enzymes to cut DNA and T4 DNA ligase to reconnect the fragments. However, restriction enzymes cut only at specific sequences and generate sticky ends that are often too short, thereby limiting joining efficiency.
To address this limitation, a research team led by Professor Hiroshi Abe and Assistant Professor Masahito Inagaki at Nagoya University, in collaboration with Professor Natsuhisa Oka at Gifu University, studied DNA cleavage at targeted sites using chemical reactions instead of restriction enzymes.
The researchers examined a reaction reported between 1990 and 1992, in which silver ions cleave 3′-thiol-modified DNA at specific sites. They assessed its potential to generate suitable sticky ends. Results showed that although silver ions efficiently cleave DNA, they also bind nonspecifically, leading to precipitation. This resulted in a low DNA recovery rate of about 14%, which is insufficient for practical use.
The team then employed silver nanoparticles instead, hypothesizing that these could be removed after the reaction through centrifugation, thereby potentially increasing DNA recovery.
Experiments showed that DNA-cleaving efficiency reached about 50% at 70°C and nearly 100% at 95°C within two hours. However, these high temperatures pose a risk of damaging long-chain DNA.
To address this, the team coated the nanoparticles with polyethylene glycol (PEG), a water-soluble polymer, to enhance stability and dispersion. This modification increased cleaving efficiency from 36% without PEG to 92% with PEG at 37°C over 31 hours. “In the end, we optimized the conditions to a practical level and, under ambient temperatures, achieved PEG-modified cleaving efficiency above 91% at 50°C within just one to two hours,” stated Inagaki, the study’s first author.
An additional benefit of this process was the removal of unwanted DNA fragments bound to nanoparticle surfaces, leaving only the desired fragments with sticky ends in solution. This purification process increased the final DNA recovery rate from 14% to 98%.
The use of silver nanoparticles also enabled the generation of DNA fragments with 8-base sticky ends, a process that is challenging with conventional restriction enzymes. By employing T4 DNA ligase to join these fragments, the team achieved about double the joining efficiency of traditional methods. With an 18-base overhang, joining efficiency reached 44%, compared to only 8% with a conventional 4-base overhang, representing a fivefold improvement.
To evaluate the practical application of this approach, the researchers assembled a DNA fragment encoding green fluorescent protein (GFP) and introduced it into human HeLa cells. They successfully confirmed GFP expression, indicating accurate assembly.
Inagaki commented, “We believe this technology will be useful for synthesizing genomic DNA, with many possible applications in areas such as mRNA library establishment for cancer vaccines and gene therapy, as well as the development of artificial protein drugs and genome crops.”
He also explained the next step: “We have shown that two DNA fragments can be joined. Now, we need to confirm whether multiple fragments can be joined at the same time—a key step for building genome-scale DNA.”
Funding: This work was supported by the Japan Science and Technology Agency (JST) (JPMJCR18S1, JPMJCR23N1, JP25H00427, JP24H00737, JP22H02219, and JP22K21346 International Leading Research); the Japan Agency for Medical Research and Development (AMED) (JP22gm0010008 [LEAP], JP25ak0101289, JP223fa827 [SCADA], JP243fa827032 [SCADA], JP23bm1223009, JP24ek0109697, JP25ama221315, JP25km0405209, JP25ama221230, and JP23fk0210133); and the Tanaka Kikinzoku Memorial Foundation (Precious Metals Research Grants 2021 Silver Award to M.I.). Funding to pay the open-access publication charges for this article was provided by the Japan Science and Technology Agency.
Published in journal: Nucleic Acids Research
Authors: Masahito Inagaki, Mikiya Kase, Haruka Hiraoka, Natsuhisa Oka, Fumitaka Hashiya, Naoko Abe, Yasuaki Kimura, and Hiroshi Abe
Source/Credit: Nagoya University
Edited by: Scientific Frontline
Reference Number: mbio061626_01
.png)
.jpg)